Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AACR Annual Meeting In Brief

This article was originally published in The Tan Sheet

Executive Summary

Shanghai Breast Cancer Study: Green tea consumption associated with 15% decreased breast cancer risk, Martha Shrubsole, Vanderbilt University and Shanghai Cancer Institute, et al., report at American Association of Cancer Research annual meeting in San Francisco, Calif. April 6-10. Risk further declined with increased years of green tea consumption, number of servings/day. Multivitamin intake led to 48% reduced risk, with 30%, 25%, 27% decreases in breast cancer risk associated with vitamin B, C, E consumption, respectively; no duration or dose-response correlations were detected. Ginseng use did not ameliorate breast cancer risk. Study involved in-person interviews with 1,459 cases and 1,556 controls...

You may also be interested in...



AACR 2002 follow-up

Finding that plasma homocysteine concentrations are not associated with increased breast cancer risk "seems to contradict the recently suggested role of homocysteine as a potential tumor marker," Katharina Schroecksnadel, Leopold Franzen University, Australia, et al. state in July 16 Journal of the National Cancer Institute. Comments respond to study results by Shumin Zhang, Harvard School of Public Health, et al. that found high concentrations of vitamin B12 and plasma folate were associated with a lower risk of breast cancer (1"The Tan Sheet" April 15, 2002, p. 15). Zhang and colleagues point out that the study was not meant to consider the role of homocysteine as a tumor marker, but "data would suggest that it does not appear early in the disease process"...

AACR 2002 follow-up

Finding that plasma homocysteine concentrations are not associated with increased breast cancer risk "seems to contradict the recently suggested role of homocysteine as a potential tumor marker," Katharina Schroecksnadel, Leopold Franzen University, Australia, et al. state in July 16 Journal of the National Cancer Institute. Comments respond to study results by Shumin Zhang, Harvard School of Public Health, et al. that found high concentrations of vitamin B12 and plasma folate were associated with a lower risk of breast cancer (1"The Tan Sheet" April 15, 2002, p. 15). Zhang and colleagues point out that the study was not meant to consider the role of homocysteine as a tumor marker, but "data would suggest that it does not appear early in the disease process"...

AACR 2002 follow-up

Finding that plasma homocysteine concentrations are not associated with increased breast cancer risk "seems to contradict the recently suggested role of homocysteine as a potential tumor marker," Katharina Schroecksnadel, Leopold Franzen University, Australia, et al. state in July 16 Journal of the National Cancer Institute. Comments respond to study results by Shumin Zhang, Harvard School of Public Health, et al. that found high concentrations of vitamin B12 and plasma folate were associated with a lower risk of breast cancer (1"The Tan Sheet" April 15, 2002, p. 15). Zhang and colleagues point out that the study was not meant to consider the role of homocysteine as a tumor marker, but "data would suggest that it does not appear early in the disease process"...

Related Content

Topics

UsernamePublicRestriction

Register

PS093865

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel